Mugusi, S., Habtewold, A., Ngaimisi, E., Amogne, W., Yimer, G., Minzi, O., . . . Aklillu, E. (2020). Impact of population and pharmacogenetics variations on efavirenz pharmacokinetics and immunologic outcomes during anti-tuberculosis co-therapy: A parallel prospective cohort study in two sub-Sahara African populations. Frontiers in pharmacology, 11, . https://doi.org/10.3389/fphar.2020.00026
Chicago Style (17th ed.) CitationMugusi, Sabina, et al. "Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-tuberculosis Co-therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations." Frontiers in Pharmacology 11 (2020). https://doi.org/10.3389/fphar.2020.00026.
MLA (9th ed.) CitationMugusi, Sabina, et al. "Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-tuberculosis Co-therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations." Frontiers in Pharmacology, vol. 11, 2020, https://doi.org/10.3389/fphar.2020.00026.